BioMarin Pharmaceutical $850 million debut senior notes offering
We advised the representative of the initial purchasers
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Rhône Capital acquisition of Invacare
We advised Highbridge Capital, as an Invacare secured lender and noteholder, on the transaction
LXO Group hybrid capital acquisition financing
We advised Hayfin Capital Management on its hybrid capital investment in LXO Group
LifeScan emerges from chapter 11
We advised an ad hoc group of secured lenders in connection with LifeScan’s chapter 11 proceedings
Auna $400 million refinancing
We advised Auna on the transaction
Auna $365 million senior secured notes offering and cash tender offer
We advised Auna on the offering
Blackstone and TPG $12.25 billion Hologic acquisition financing
We are advising the lead arrangers and bookrunners on the financing
Pharmaceutical company $550 million preferred equity acquisition financing
We advised the preferred equity financing sources on the transaction
Precigen $125 million financing
We advised Precigen on the loan agreement
Owens & Minor $1 billion secured notes offering
The high-yield notes are due 2030